Novel metrics to measure coverage in whole exome sequencing datasets reveal local and global non-uniformity

Qingyu Wang, Cooduvalli S. Shashikant, Matthew Jensen, Naomi S. Altman, Santhosh Girirajan

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Whole Exome Sequencing (WES) is a powerful clinical diagnostic tool for discovering the genetic basis of many diseases. A major shortcoming of WES is uneven coverage of sequence reads over the exome targets contributing to many low coverage regions, which hinders accurate variant calling. In this study, we devised two novel metrics, Cohort Coverage Sparseness (CCS) and Unevenness (UE) Scores for a detailed assessment of the distribution of coverage of sequence reads. Employing these metrics we revealed non-uniformity of coverage and low coverage regions in the WES data generated by three different platforms. This non-uniformity of coverage is both local (coverage of a given exon across different platforms) and global (coverage of all exons across the genome in the given platform). The low coverage regions encompassing functionally important genes were often associated with high GC content, repeat elements and segmental duplications. While a majority of the problems associated with WES are due to the limitations of the capture methods, further refinements in WES technologies have the potential to enhance its clinical applications.

Original languageEnglish (US)
Article number885
JournalScientific reports
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

Exome
Exons
Genomic Segmental Duplications
Base Composition
Datasets
Genome
Technology
Genes

All Science Journal Classification (ASJC) codes

  • General

Cite this

@article{c2bc7f116f4d4ff1aeaa94c5ecb06dc0,
title = "Novel metrics to measure coverage in whole exome sequencing datasets reveal local and global non-uniformity",
abstract = "Whole Exome Sequencing (WES) is a powerful clinical diagnostic tool for discovering the genetic basis of many diseases. A major shortcoming of WES is uneven coverage of sequence reads over the exome targets contributing to many low coverage regions, which hinders accurate variant calling. In this study, we devised two novel metrics, Cohort Coverage Sparseness (CCS) and Unevenness (UE) Scores for a detailed assessment of the distribution of coverage of sequence reads. Employing these metrics we revealed non-uniformity of coverage and low coverage regions in the WES data generated by three different platforms. This non-uniformity of coverage is both local (coverage of a given exon across different platforms) and global (coverage of all exons across the genome in the given platform). The low coverage regions encompassing functionally important genes were often associated with high GC content, repeat elements and segmental duplications. While a majority of the problems associated with WES are due to the limitations of the capture methods, further refinements in WES technologies have the potential to enhance its clinical applications.",
author = "Qingyu Wang and Shashikant, {Cooduvalli S.} and Matthew Jensen and Altman, {Naomi S.} and Santhosh Girirajan",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-01005-x",
language = "English (US)",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

Novel metrics to measure coverage in whole exome sequencing datasets reveal local and global non-uniformity. / Wang, Qingyu; Shashikant, Cooduvalli S.; Jensen, Matthew; Altman, Naomi S.; Girirajan, Santhosh.

In: Scientific reports, Vol. 7, No. 1, 885, 01.12.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Novel metrics to measure coverage in whole exome sequencing datasets reveal local and global non-uniformity

AU - Wang, Qingyu

AU - Shashikant, Cooduvalli S.

AU - Jensen, Matthew

AU - Altman, Naomi S.

AU - Girirajan, Santhosh

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Whole Exome Sequencing (WES) is a powerful clinical diagnostic tool for discovering the genetic basis of many diseases. A major shortcoming of WES is uneven coverage of sequence reads over the exome targets contributing to many low coverage regions, which hinders accurate variant calling. In this study, we devised two novel metrics, Cohort Coverage Sparseness (CCS) and Unevenness (UE) Scores for a detailed assessment of the distribution of coverage of sequence reads. Employing these metrics we revealed non-uniformity of coverage and low coverage regions in the WES data generated by three different platforms. This non-uniformity of coverage is both local (coverage of a given exon across different platforms) and global (coverage of all exons across the genome in the given platform). The low coverage regions encompassing functionally important genes were often associated with high GC content, repeat elements and segmental duplications. While a majority of the problems associated with WES are due to the limitations of the capture methods, further refinements in WES technologies have the potential to enhance its clinical applications.

AB - Whole Exome Sequencing (WES) is a powerful clinical diagnostic tool for discovering the genetic basis of many diseases. A major shortcoming of WES is uneven coverage of sequence reads over the exome targets contributing to many low coverage regions, which hinders accurate variant calling. In this study, we devised two novel metrics, Cohort Coverage Sparseness (CCS) and Unevenness (UE) Scores for a detailed assessment of the distribution of coverage of sequence reads. Employing these metrics we revealed non-uniformity of coverage and low coverage regions in the WES data generated by three different platforms. This non-uniformity of coverage is both local (coverage of a given exon across different platforms) and global (coverage of all exons across the genome in the given platform). The low coverage regions encompassing functionally important genes were often associated with high GC content, repeat elements and segmental duplications. While a majority of the problems associated with WES are due to the limitations of the capture methods, further refinements in WES technologies have the potential to enhance its clinical applications.

UR - http://www.scopus.com/inward/record.url?scp=85018178586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018178586&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-01005-x

DO - 10.1038/s41598-017-01005-x

M3 - Article

C2 - 28408746

AN - SCOPUS:85018178586

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 885

ER -